Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition

Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic progression and improved survival; Results from Phase 1 clinical trial in ...

ABVC BioPharma Receives US$240,000 Licensing Payment From OncoX BioPharma; Total Licensing Payments Reach Approximately US$2.53 Million

ABVC BioPharma, Inc. (NASDAQ: ABVC) ("ABVC" or the "Company") today announced that it has received an additional US$240,000 licensing payment from its partner OncoX BioPharma, Inc. ("OncoX") ...